Top 15 Trending Stocks On WallStreetBets As Of Thursday, Mar. 16, 2023 (Via Swaggy Stocks)
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Nvidia (NVDA)
Meta Platforms (META)
Advanced Micro Devices (AMD)
Tesla (TSLA)
Invesco QQQ Trust (QQQ)
C3.ai (AI)
FedEx
Netcapital Q3 EPS $0.33, Sales $2.26M
Netcapital (NASDAQ:NCPL) reported quarterly earnings of $0.33 per share. The company reported $2.26 million in sales this quarter.
Impac Mortgage Holdings Q4 Adj. EPS $(0.35) Down From $(0.23) YoY, Sales $1.07M Down From $14.94M YoY
Impac Mortgage Holdings (AMEX:IMH) reported quarterly losses of $(0.35) per share. This is a 52.17 percent decrease over losses of $(0.23) per share from the same period last year. The company reported $1.07 million in
2seventy bio Q4 EPS $(0.60), Sales $56.18M
2seventy bio (NASDAQ:TSVT) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(1.61) by 62.73 percent. This is a 76.47 percent increase over losses of $(2.55) per share from the
Purple Innovation Q4 Adj. EPS $(0.10) Misses $(0.06) Estimate, Sales $145.12M Beat $144.16M Estimate
Purple Innovation (NASDAQ:PRPL) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.06) by 66.67 percent. This is a 71.43 percent increase over losses of $(0.35) per share
Sarcos Technology Q4 Adj. EPS $(0.12) Beats $(0.15) Estimate, Sales $6.12M Beat $5.70M Estimate
Sarcos Technology (NASDAQ:STRC) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 9.09 percent decrease over losses of $(0.11) per share from the
Akumin Q4 EPS $(0.46) Down From $(0.36) YoY, Sales $184.63M Beat $183.90M Estimate
Akumin (NASDAQ:AKU) reported quarterly losses of $(0.46) per share. This is a 27.78 percent decrease over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $184.63
Eiger BioPharmaceuticals Q4 EPS $(0.57) Misses $(0.54) Estimate, Sales $2.70M May Not Compare To $4.43M Estimate
Eiger BioPharmaceuticals (NASDAQ:EIGR) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.54) by 5.56 percent. This is a 10.94 percent increase over losses of $(0.64) per
Lifecore Biomedical Q2 EPS $(0.24) Misses $0.03 Estimate, Sales $38.80M Miss $54.54M Estimate
Lifecore Biomedical, Inc. - Common Stock (NASDAQ:LFCR) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $0.03 by 900 percent. This is a 4 percent increase over losses of